Can good blood glucose control be reached with a decision support system in patients who underwent stemm cell transplantatio

Phase 1

• Conditions: Hyperglycaemic patients; Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]

• Registration Number: EUCTR2014-004418-27-AT
• Lead Sponsor: Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. f. Endokrinologie und Stoffwechsel

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-03-18
• Last Update Posted: 19 February 2024

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

•Age between 18 and 60 years
•Patients after allogeneic stem cell transplantation who are hospitalized for GVHD and have overt hyperglycaemia requiring glucose lowering treatment
•Signed informed consent

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 10
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 10

Exclusion Criteria

•Known or suspected allergy to certain insulin types, named in the user manual
•Total parenteral nutrition
•Any mental condition rendering the patient incapable of giving his consent

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified